TrialClinical pharmacology in drug development2025
Safety, Tolerability, and Pharmacokinetics of Galcanezumab, an Anti-CGRP Antibody, in Healthy Chinese Participants.
Jingjing Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.